Study: NCT02224521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Solution.
Description: Aqueous Solution, 10mg/mL.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Solution.
Description: Aqueous Solution, 10mg/mL.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Solution.
Description: Aqueous Solution, 10mg/mL.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Solution.
Description: Aqueous Solution, 10mg/mL.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Granule Capsule (A)
Description: GSK2190915A granule filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Granule Capsule (A)
Description: GSK2190915A granule filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Granule Capsule (A)
Description: GSK2190915A granule filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Granule Capsule (A)
Description: GSK2190915A granule filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Semi-solid Lipid Capsule (B)
Description: GSK2190915A dispersed in a lipid vehicle and filled in to HPMC capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Semi-solid Lipid Capsule (B)
Description: GSK2190915A dispersed in a lipid vehicle and filled in to HPMC capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Semi-solid Lipid Capsule (B)
Description: GSK2190915A dispersed in a lipid vehicle and filled in to HPMC capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Semi-solid Lipid Capsule (B)
Description: GSK2190915A dispersed in a lipid vehicle and filled in to HPMC capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Liquid Lipid Capsule (C)
Description: GSK2190915A dissolved in lipid vehicle milled and filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Liquid Lipid Capsule (C)
Description: GSK2190915A dissolved in lipid vehicle milled and filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Liquid Lipid Capsule (C)
Description: GSK2190915A dissolved in lipid vehicle milled and filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Liquid Lipid Capsule (C)
Description: GSK2190915A dissolved in lipid vehicle milled and filled in to Gelatin capsules

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Milled Tablet
Description: GSK2190915A granule is blended, compressed into tablets and aqueous film coated

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Milled Tablet
Description: GSK2190915A granule is blended, compressed into tablets and aqueous film coated

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Micronised Tablet
Description: GSK2190915A granule is blended, compressed into tablets and aqueous film coated

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 Micronised Tablet
Description: GSK2190915A granule is blended, compressed into tablets and aqueous film coated